Monsanto Company (MON) Shares Sold by Moloney Securities Asset Management LLC
Moloney Securities Asset Management LLC cut its holdings in shares of Monsanto Company (NYSE:MON) by 22.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,232 shares of the basic materials company’s stock after selling 1,194 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Monsanto were worth $507,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. United Services Automobile Association raised its stake in shares of Monsanto by 5.6% in the first quarter. United Services Automobile Association now owns 265,378 shares of the basic materials company’s stock valued at $30,041,000 after purchasing an additional 14,076 shares in the last quarter. Nikko Asset Management Americas Inc. raised its stake in shares of Monsanto by 1.3% in the second quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock valued at $53,345,000 after purchasing an additional 5,700 shares in the last quarter. Aviva PLC raised its stake in shares of Monsanto by 1.2% in the second quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock valued at $36,052,000 after purchasing an additional 3,569 shares in the last quarter. WFG Advisors LP raised its stake in shares of Monsanto by 19.4% in the first quarter. WFG Advisors LP now owns 2,377 shares of the basic materials company’s stock valued at $269,000 after purchasing an additional 387 shares in the last quarter. Finally, Wealthfront Inc. acquired a new position in shares of Monsanto in the second quarter valued at $1,680,000. Institutional investors own 74.77% of the company’s stock.
MON has been the subject of a number of recent research reports. UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Susquehanna Bancshares Inc restated a “neutral” rating and issued a $128.00 target price (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Tuesday, June 27th. Royal Bank Of Canada restated a “sector perform” rating and issued a $128.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Finally, Barclays PLC upped their target price on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, June 29th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $124.61.
In related news, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the sale, the vice president now owns 38,600 shares in the company, valued at approximately $4,718,850. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Duraiswami Narain sold 2,860 shares of the business’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 44,916 shares of company stock worth $5,404,894 in the last 90 days. 0.79% of the stock is currently owned by corporate insiders.
Shares of Monsanto Company (MON) traded up 0.10% during mid-day trading on Friday, hitting $122.15. The stock had a trading volume of 1,551,434 shares. The stock has a 50 day moving average price of $119.36 and a 200 day moving average price of $117.53. The firm has a market cap of $53.68 billion, a PE ratio of 24.00 and a beta of 1.07. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $122.80.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The business had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.07 EPS. Equities research analysts expect that Monsanto Company will post $5.70 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.77%. Monsanto’s dividend payout ratio is currently 42.27%.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.